SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-013849
Filing Date
2023-04-21
Accepted
2023-04-21 16:15:36
Documents
12
Period of Report
2023-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K prds-20230418.htm   iXBRL 8-K 59697
  Complete submission text file 0000950170-23-013849.txt   184497

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20230418.xsd EX-101.SCH 2467
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20230418_pre.xml EX-101.PRE 11867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20230418_lab.xml EX-101.LAB 14460
6 EXTRACTED XBRL INSTANCE DOCUMENT prds-20230418_htm.xml XML 5068
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40067 | Film No.: 23836545
SIC: 2834 Pharmaceutical Preparations